Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $38.55M.
ENTERPRISE VALUE (EV)
$38.55M
OnKure Therapeutics, Inc.
Market Cap
$97.60M
Enterprise Value (EV)
$38.55M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| OnKure Therapeutics, Inc. (OKUR) | $97.60M | $38.55M |
| Korro Bio, Inc. (KRRO)vs › | $97.44M | $114.75M |
| Conexeu Sciences Inc. (CNXU)vs › | $96.87M | N/A |
| PolyPid Ltd. (PYPD)vs › | $96.75M | $91.76M |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $96.58M | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $94.90M | $67.01M |
| The Joint Corp. (JYNT)vs › | $101.36M | $81.24M |
| Anixa Biosciences, Inc. (ANIX)vs › | $103.09M | $101.87M |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $104.00M | $101.78M |
| Biomea Fusion, Inc. (BMEA)vs › | $91.10M | $57.15M |
Market Cap
$97.60M
Total Debt
$0.00
Cash
$59.05M
Enterprise Value
$38.55M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
